{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:57:58Z","timestamp":1789055878081,"version":"build-2803163510"},"reference-count":45,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J STD AIDS"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sexually transmitted infections (STIs) are increasing globally. To improve understanding of the epidemiology of STIs in key populations, we analysed sentinel surveillance data on STI test positivity among individuals tested using subsidised tests at anonymous walk-in clinics in North Rhine-Westphalia (NRW), Germany.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a cross-sectional analysis of sentinel surveillance data from all 53 local health authority anonymous walk-in clinics in NRW during 2021. Test positivity for HIV, syphilis, chlamydia, and gonorrhoea was analysed by key population group. We used univariable and multivariable logistic regression to examine factors associated with each infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 11,560 consultations, overall STI test positivity was 6.6%. Chlamydia was the most frequently detected (6.4%), followed by gonorrhoea (2.7%), syphilis (0.9%), and HIV (0.6%). We observed disparities in STI test positivity among key population groups. Men-who-have-sex-with-men (MSM) (aOR 1.93; 95%CI 1.38\u20132.68), sex work (aOR 2.77; 95%CI 1.9\u20133.96), and having an STI-positive partner (aOR 1.71; 95%CI 1.30\u20132.22) were associated with increased STI risk. Coinfections were rare (0.4%) and predominantly occurred among MSM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Anonymous walk-in clinics reach diverse high-risk populations with substantial STI burdens. Findings support targeted prevention strategies for key populations and highlight the importance of comprehensive STI screening in anonymous settings for surveillance and case detection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09564624251384543","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:19:29Z","timestamp":1759533569000},"page":"212-221","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Sexually transmitted infection test positivity and associated factors in individuals tested at anonymous clinics in North Rhine-Westphalia state, Germany, 2021"],"prefix":"10.1177","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2253-7496","authenticated-orcid":false,"given":"Katja","family":"Siling","sequence":"first","affiliation":[{"name":"State Office for Health and Occupational Safety of North Rhine-Westphalia (LfGA NRW)"},{"name":"London School of Hygiene & Tropical Medicine (LSHTM)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Grotegut","sequence":"additional","affiliation":[{"name":"State Office for Health and Occupational Safety of North Rhine-Westphalia (LfGA NRW)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma M.","family":"Harding-Esch","sequence":"additional","affiliation":[{"name":"London School of Hygiene & Tropical Medicine (LSHTM)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Jurke","sequence":"additional","affiliation":[{"name":"State Office for Health and Occupational Safety of North Rhine-Westphalia (LfGA NRW)"},{"name":"University of Muenster"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2023.12.002"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00448-5"},{"key":"e_1_3_6_4_2","volume-title":"A systematic review and meta-analysis of the prevalence of chlamydia, gonorrhoea, trichomoniasis and syphilis in Europe","author":"European Centre for Disease Prevention and Control","year":"2024","unstructured":"European Centre for Disease Prevention and Control. A systematic review and meta-analysis of the prevalence of chlamydia, gonorrhoea, trichomoniasis and syphilis in Europe. Stockholm: ECDC, 2024."},{"key":"e_1_3_6_5_2","first-page":"6","article-title":"Einf\u00fchrung einer Meldepflicht f\u00fcr N. gonorrhoeae mit verminderter Empfindlichkeit gegen\u00fcber Azithromycin, Cefixim oder Ceftriaxon","volume":"10","author":"Selb R","year":"2020","unstructured":"Selb R, Bremer V, Jansen K, et al. Einf\u00fchrung einer Meldepflicht f\u00fcr N. gonorrhoeae mit verminderter Empfindlichkeit gegen\u00fcber Azithromycin, Cefixim oder Ceftriaxon. Epid Bull. 2020; 10: 6\u201312.","journal-title":"Epid Bull"},{"key":"e_1_3_6_6_2","unstructured":"Federal Ministry of Justice. Gesetz zur Verh\u00fctung und Bek\u00e4mpfung von Infektionskrankheiten beim Menschen (Infektionsschutzgesetz - IfSG). https:\/\/www.gesetze-im-internet.de\/ifsg\/BJNR104510000.html (accessed 26 September 2024)."},{"key":"e_1_3_6_7_2","volume-title":"Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten f\u00fcr 2022","author":"Robert Koch-Institut","year":"2024","unstructured":"Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten f\u00fcr 2022. Berlin: Robert Koch-Institut, 2024."},{"key":"e_1_3_6_8_2","unstructured":"Robert Koch Institut. Umsetzung der neu eingef\u00fchrten Meldepflichten nach \u00a77 Abs. 3 IfSG: Meldung von Neisseria gonorrhoeae und Chlamydia trachomatis. https:\/\/www.rki.de\/DE\/Themen\/Infektionskrankheiten\/Infektionskrankheiten-A-Z\/G\/Gonorrhoe\/Meldepflicht_IfSG.html (2023 accessed 27 April 2025)."},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.5414\/CP203173"},{"key":"e_1_3_6_10_2","first-page":"Doc03","article-title":"Prevalence and treatment of sexually transmitted infections in men followed by urologists in Germany - a cross sectional study with 347,090 men","volume":"16","author":"Jacob L","year":"2018","unstructured":"Jacob L, Duse DA, Kostev K. Prevalence and treatment of sexually transmitted infections in men followed by urologists in Germany - a cross sectional study with 347,090 men. Ger Med Sci 2018; 16: Doc03.","journal-title":"Ger Med Sci"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1915-2"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.793609"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16913"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-4831-4"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2012-050929"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-016-3847-6"},{"key":"e_1_3_6_17_2","first-page":"3","article-title":"HIV-Jahresbericht 2023","volume":"40","author":"Marcus U","year":"2024","unstructured":"Marcus U, Kollan C, Gunsenheimer-Bartmeyer B, et al. HIV-Jahresbericht 2023. Epid Bull 2024; 40: 3\u201320.","journal-title":"Epid Bull"},{"key":"e_1_3_6_18_2","first-page":"3","article-title":"Syphilis in Deutschland in den Jahren 2020\u20132022 \u2013 Neuer H\u00f6chststand von Infektionen nach R\u00fcckgang w\u00e4hrend der COVID-19-Pandemie","volume":"7","author":"Jansen K","year":"2024","unstructured":"Jansen K, Bremer V. Syphilis in Deutschland in den Jahren 2020\u20132022 \u2013 Neuer H\u00f6chststand von Infektionen nach R\u00fcckgang w\u00e4hrend der COVID-19-Pandemie. Epid Bull 2024; 7: 3\u201324.","journal-title":"Epid Bull"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-927257"},{"key":"e_1_3_6_20_2","volume-title":"Integrated strategy for HIV, hepatitis B and C and other sexually transmitted infections","author":"Federal Ministry of Health; the Federal Ministry for Economic Cooperation and Development","year":"2016","unstructured":"Federal Ministry of Health; the Federal Ministry for Economic Cooperation and Development. Integrated strategy for HIV, hepatitis B and C and other sexually transmitted infections. Berlin: Federal Ministry of Health and the Federal Ministry for Economic Cooperation and Development, 2016."},{"key":"e_1_3_6_21_2","volume-title":"RStudio: integrated development for R","author":"RStudio Team","year":"2019","unstructured":"RStudio Team. RStudio: integrated development for R. Boston, MA: RStudio, Inc., 2019."},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00171-3"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00356-0"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07171-2"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000889"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.10577"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100743"},{"key":"e_1_3_6_28_2","volume-title":"Global health sector strategy on sexually transmitted infections 2016-2021","author":"World Health Organization (WHO)","year":"2016","unstructured":"World Health Organization (WHO). Global health sector strategy on sexually transmitted infections 2016-2021. Geneva: WHO, 2016."},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.14.2100591"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.43.30382"},{"key":"e_1_3_6_31_2","first-page":"3","article-title":"Estimate of the number of new HIV infections in 2022 and 2023 and the total number of people living with HIV in Germany at the end of 2023","volume":"28","author":"an der Heiden M","year":"2024","unstructured":"an der Heiden M, Marcus U, Kollan C, et al. Estimate of the number of new HIV infections in 2022 and 2023 and the total number of people living with HIV in Germany at the end of 2023. Epid Bull 2024; 28: 3\u201320.","journal-title":"Epid Bull"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-017-1799-1"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001400"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001085"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0313868"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab489"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckac131.200"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2019.105779"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0045-1801955"},{"key":"e_1_3_6_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/00333549091240S203"},{"key":"e_1_3_6_41_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.150653"},{"key":"e_1_3_6_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13426"},{"key":"e_1_3_6_43_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.47.2001943"},{"key":"e_1_3_6_44_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-12390-4"},{"key":"e_1_3_6_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002581"},{"key":"e_1_3_6_46_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.949077"}],"container-title":["International Journal of STD &amp; AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09564624251384543","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09564624251384543","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09564624251384543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:47:11Z","timestamp":1777675631000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09564624251384543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1177\/09564624251384543"],"URL":"https:\/\/doi.org\/10.1177\/09564624251384543","relation":{},"ISSN":["0956-4624","1758-1052"],"issn-type":[{"value":"0956-4624","type":"print"},{"value":"1758-1052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]}}}